Academic Journal
Striving toward hepatitis C elimination in the era of COVID-19.
| Title: | Striving toward hepatitis C elimination in the era of COVID-19. |
|---|---|
| Authors: | Lanièce Delaunay C; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Greenwald ZR; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Minoyan N; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.; Département de Médecine Sociale et Préventive, École de Santé Publique, Université de Montréal, Montreal, Quebec, Canada., Artenie AA; Population Health Sciences, University of Bristol, Bristol, United Kingdom., Jeong D; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada., Marathe G; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada., Saeed YA; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Kolla G; Canadian Centre for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada., Kunden RD; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Okwor CIA; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, Canada., Wallace HL; Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada., Mendlowitz A; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada., Liu CH; Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan., Mazouz S; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada., D'souza S; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Perciani CT; Soham and Shaila Ajmera Family Transplant Centre, Toronto General Hospital Research Institute, Toronto, Ontario, Canada., Rheault M; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada., Palmer MA; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Palayew A; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Abdelnabi MN; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Cunningham EB; Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia. |
| Source: | Canadian liver journal [Can Liver J] 2021 Feb 24; Vol. 4 (1), pp. 4-7. Date of Electronic Publication: 2021 Feb 24 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: University of Toronto Press Country of Publication: Canada NLM ID: 101778326 Publication Model: eCollection Cited Medium: Internet ISSN: 2561-4444 (Electronic) Linking ISSN: 25614444 NLM ISO Abbreviation: Can Liver J Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Toronto, ON Canada : University of Toronto Press, [2018]- |
| Competing Interests: | The authors have no conflict of interest to disclose. |
| References: | AIDS Behav. 2021 Feb;25(2):354-359. (PMID: 32705370) Int J Drug Policy. 2020 Sep;83:102821. (PMID: 32591222) Drug Alcohol Depend. 2020 Sep 1;214:108176. (PMID: 32717504) Liver Int. 2020 Mar;40(3):522-529. (PMID: 31815353) BMJ. 2020 Jun 9;369:m2294. (PMID: 32518177) AIDS Behav. 2020 Sep;24(9):2466-2468. (PMID: 32333209) Int J Drug Policy. 2020 Sep;83:102880. (PMID: 32739148) Hepatology. 2020 Aug;72(2):723-728. (PMID: 32275784) Int J Drug Policy. 2020 Sep;83:102832. (PMID: 32654930) JAMA Netw Open. 2020 May 1;3(5):e204192. (PMID: 32374397) Int J Drug Policy. 2020 Sep;83:102851. (PMID: 32736959) Int J Drug Policy. 2020 Sep;83:102895. (PMID: 32741718) BMC Infect Dis. 2018 Jun 19;18(1):281. (PMID: 29914381) J Hepatol. 2021 Jan;74(1):31-36. (PMID: 32777322) J Int AIDS Soc. 2020 Jul;23(7):e25583. (PMID: 32697423) |
| Contributed Indexing: | Keywords: COVID-19; SARS-CoV-2; hepatitis C elimination; people who use drugs Author Affiliation; priority populations |
| Entry Date(s): | Date Created: 20220822 Latest Revision: 20220823 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC9203169 |
| DOI: | 10.3138/canlivj-2020-0027 |
| PMID: | 35991473 |
| Database: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=25614444&ISBN=&volume=4&issue=1&date=20210224&spage=4&pages=4-7&title=Canadian liver journal&atitle=Striving%20toward%20hepatitis%20C%20elimination%20in%20the%20era%20of%20COVID-19.&aulast=Lani%C3%A8ce%20Delaunay%20C&id=DOI:10.3138/canlivj-2020-0027 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 35991473 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Striving toward hepatitis C elimination in the era of COVID-19. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lanièce+Delaunay+C%22">Lanièce Delaunay C</searchLink>; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Greenwald+ZR%22">Greenwald ZR</searchLink>; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Minoyan+N%22">Minoyan N</searchLink>; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.; Département de Médecine Sociale et Préventive, École de Santé Publique, Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Artenie+AA%22">Artenie AA</searchLink>; Population Health Sciences, University of Bristol, Bristol, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jeong+D%22">Jeong D</searchLink>; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.; British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Marathe+G%22">Marathe G</searchLink>; Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, McGill University, Montreal, Quebec, Canada.; Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Saeed+YA%22">Saeed YA</searchLink>; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kolla+G%22">Kolla G</searchLink>; Canadian Centre for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Kunden+RD%22">Kunden RD</searchLink>; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.<br /><searchLink fieldCode="AU" term="%22Okwor+CIA%22">Okwor CIA</searchLink>; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wallace+HL%22">Wallace HL</searchLink>; Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.<br /><searchLink fieldCode="AU" term="%22Mendlowitz+A%22">Mendlowitz A</searchLink>; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Toronto Health Economics and Technology Assessment (THETA) Collaborative, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Liu+CH%22">Liu CH</searchLink>; Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Mazouz+S%22">Mazouz S</searchLink>; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22D'souza+S%22">D'souza S</searchLink>; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Perciani+CT%22">Perciani CT</searchLink>; Soham and Shaila Ajmera Family Transplant Centre, Toronto General Hospital Research Institute, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Rheault+M%22">Rheault M</searchLink>; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Palmer+MA%22">Palmer MA</searchLink>; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.<br /><searchLink fieldCode="AU" term="%22Palayew+A%22">Palayew A</searchLink>; Department of Epidemiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Abdelnabi+MN%22">Abdelnabi MN</searchLink>; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Cunningham+EB%22">Cunningham EB</searchLink>; Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101778326%22">Canadian liver journal</searchLink> [Can Liver J] 2021 Feb 24; Vol. 4 (1), pp. 4-7. <i>Date of Electronic Publication: </i>2021 Feb 24 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22University+of+Toronto+Press%22">University of Toronto Press </searchLink><i>Country of Publication: </i>Canada <i>NLM ID: </i>101778326 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2561-4444 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225614444%22">25614444 </searchLink><i>NLM ISO Abbreviation: </i>Can Liver J <i>Subsets: </i>PubMed not MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Toronto, ON Canada : University of Toronto Press, [2018]- – Name: Abstract Label: Competing Interests Group: Ab Data: The authors have no conflict of interest to disclose. – Name: Ref Label: References Group: RefInfo Data: AIDS Behav. 2021 Feb;25(2):354-359. (PMID: <searchLink fieldCode="PM" term="%2232705370%22">32705370)</searchLink><br />Int J Drug Policy. 2020 Sep;83:102821. (PMID: <searchLink fieldCode="PM" term="%2232591222%22">32591222)</searchLink><br />Drug Alcohol Depend. 2020 Sep 1;214:108176. (PMID: <searchLink fieldCode="PM" term="%2232717504%22">32717504)</searchLink><br />Liver Int. 2020 Mar;40(3):522-529. (PMID: <searchLink fieldCode="PM" term="%2231815353%22">31815353)</searchLink><br />BMJ. 2020 Jun 9;369:m2294. (PMID: <searchLink fieldCode="PM" term="%2232518177%22">32518177)</searchLink><br />AIDS Behav. 2020 Sep;24(9):2466-2468. (PMID: <searchLink fieldCode="PM" term="%2232333209%22">32333209)</searchLink><br />Int J Drug Policy. 2020 Sep;83:102880. (PMID: <searchLink fieldCode="PM" term="%2232739148%22">32739148)</searchLink><br />Hepatology. 2020 Aug;72(2):723-728. (PMID: <searchLink fieldCode="PM" term="%2232275784%22">32275784)</searchLink><br />Int J Drug Policy. 2020 Sep;83:102832. (PMID: <searchLink fieldCode="PM" term="%2232654930%22">32654930)</searchLink><br />JAMA Netw Open. 2020 May 1;3(5):e204192. (PMID: <searchLink fieldCode="PM" term="%2232374397%22">32374397)</searchLink><br />Int J Drug Policy. 2020 Sep;83:102851. (PMID: <searchLink fieldCode="PM" term="%2232736959%22">32736959)</searchLink><br />Int J Drug Policy. 2020 Sep;83:102895. (PMID: <searchLink fieldCode="PM" term="%2232741718%22">32741718)</searchLink><br />BMC Infect Dis. 2018 Jun 19;18(1):281. (PMID: <searchLink fieldCode="PM" term="%2229914381%22">29914381)</searchLink><br />J Hepatol. 2021 Jan;74(1):31-36. (PMID: <searchLink fieldCode="PM" term="%2232777322%22">32777322)</searchLink><br />J Int AIDS Soc. 2020 Jul;23(7):e25583. (PMID: <searchLink fieldCode="PM" term="%2232697423%22">32697423)</searchLink> – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>COVID-19; SARS-CoV-2; hepatitis C elimination; people who use drugs Author Affiliation; priority populations – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20220822 <i>Latest Revision: </i>20220823 – Name: DateUpdate Label: Update Code Group: Date Data: 20260130 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC9203169 – Name: DOI Label: DOI Group: ID Data: 10.3138/canlivj-2020-0027 – Name: AN Label: PMID Group: ID Data: 35991473 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=35991473 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3138/canlivj-2020-0027 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4 Titles: – TitleFull: Striving toward hepatitis C elimination in the era of COVID-19. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lanièce Delaunay C – PersonEntity: Name: NameFull: Greenwald ZR – PersonEntity: Name: NameFull: Minoyan N – PersonEntity: Name: NameFull: Artenie AA – PersonEntity: Name: NameFull: Jeong D – PersonEntity: Name: NameFull: Marathe G – PersonEntity: Name: NameFull: Saeed YA – PersonEntity: Name: NameFull: Kolla G – PersonEntity: Name: NameFull: Kunden RD – PersonEntity: Name: NameFull: Okwor CIA – PersonEntity: Name: NameFull: Wallace HL – PersonEntity: Name: NameFull: Mendlowitz A – PersonEntity: Name: NameFull: Liu CH – PersonEntity: Name: NameFull: Mazouz S – PersonEntity: Name: NameFull: D'souza S – PersonEntity: Name: NameFull: Perciani CT – PersonEntity: Name: NameFull: Rheault M – PersonEntity: Name: NameFull: Palmer MA – PersonEntity: Name: NameFull: Palayew A – PersonEntity: Name: NameFull: Abdelnabi MN – PersonEntity: Name: NameFull: Cunningham EB IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 02 Text: 2021 Feb 24 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2561-4444 Numbering: – Type: volume Value: 4 – Type: issue Value: 1 Titles: – TitleFull: Canadian liver journal Type: main |
| ResultId | 1 |